News in Brief
Life Sciences - Oct 15
New system developed for rapid SARS-CoV-2 variant characterization and facilitated drug development
New system developed for rapid SARS-CoV-2 variant characterization and facilitated drug development
Health - Oct 15
Roche announces PathAI collaboration for artificial intelligence-based digital pathology applications for improved patient care
Roche announces PathAI collaboration for artificial intelligence-based digital pathology applications for improved patient care
Pharmacology - Oct 15
US FDA approves Roche's Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer
US FDA approves Roche's Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer
Pharmacology - Oct 14
Roche's Gazyvaro shorter 90-minute infusion time approved in Europe for people with previously treated or untreated follicular lymphoma
Roche's Gazyvaro shorter 90-minute infusion time approved in Europe for people with previously treated or untreated follicular lymphoma
news
« BACK
Materials Science - Architecture - 06.10.2021 
Light construction, efficient operation
Boasting an intricate, doubly curved concrete roof, lightweight funicular floors, and self-learning building technology, the latest addition to Empa and Eawag's NEST research building in Duebendorf, Switzerland officially opened today. The innovative unit illustrates nearly a decade of formative ETH Zurich research in architecture and sustainable technologies.
Environment - Architecture - 18.05.2021 
Rising energy demand for cooling
Climate-related temperature rises will further increase the cooling demand of buildings. A projection by researchers based on data from the NEST building and future climate scenarios for Switzerland shows that this increase in energy demand for cooling is likely to be substantial and could have a strong impact on our future - electrified - energy system.
Architecture - 20.05.2020 
How organic architecture can shape dense, diverse cityscapes
In a new book, researchers from EPFL examine the history of organic architecture, complete with telling examples of the genre, from its emergence in the early 20th century to the present day.
Architecture - Health - 04.05.2020
Materials Science - Architecture - 15.01.2018
Architecture - Environment - 03.06.2017 
A self-sufficient home with solar panels installed only on its facade
EPFL, in association with the School of Engineering and Architecture of Fribourg, the Geneva School of Art and Design and the University of Fribourg, is taking part in the 2017 international Solar Decathlon competition.
Architecture - Environment - 05.11.2012 
The historical value of pre-fabricated buildings
Is post-war industrial and pre-fab architecture worth preserving and renovating? To answer this question, architects conducted a three-year pioneering study into the restoration of modern buildings.
Materials Science - Architecture - 08.06.2012 
A solar sandwich to power future buildings
All in one: A new electricity generating building component is being developed.
Architecture
Results 1 - 8 of 8.
Boasting an intricate, doubly curved concrete roof, lightweight funicular floors, and self-learning building technology, the latest addition to Empa and Eawag's NEST research building in Duebendorf, Switzerland officially opened today. The innovative unit illustrates nearly a decade of formative ETH Zurich research in architecture and sustainable technologies.
Climate-related temperature rises will further increase the cooling demand of buildings. A projection by researchers based on data from the NEST building and future climate scenarios for Switzerland shows that this increase in energy demand for cooling is likely to be substantial and could have a strong impact on our future - electrified - energy system.
In a new book, researchers from EPFL examine the history of organic architecture, complete with telling examples of the genre, from its emergence in the early 20th century to the present day.
Epidiemology and urban planning: the views of Sascha Roesler on the NZZ
What is the relationship between epidiemology and urban planning? Sascha Roesler, assistant professor at the USI Academy of Achitecture (Institute for the History and Theory of Art and Architecture, ISA), explores the subject in a recently published article in the Neue Zürcher Zeitung and with a short video, showing how these two concepts have a common history and future.
What is the relationship between epidiemology and urban planning? Sascha Roesler, assistant professor at the USI Academy of Achitecture (Institute for the History and Theory of Art and Architecture, ISA), explores the subject in a recently published article in the Neue Zürcher Zeitung and with a short video, showing how these two concepts have a common history and future.
EPFL, in association with the School of Engineering and Architecture of Fribourg, the Geneva School of Art and Design and the University of Fribourg, is taking part in the 2017 international Solar Decathlon competition.
Is post-war industrial and pre-fab architecture worth preserving and renovating? To answer this question, architects conducted a three-year pioneering study into the restoration of modern buildings.
All in one: A new electricity generating building component is being developed.
News in Brief
Life Sciences - Oct 15
New system developed for rapid SARS-CoV-2 variant characterization and facilitated drug development
New system developed for rapid SARS-CoV-2 variant characterization and facilitated drug development
Health - Oct 15
Roche announces PathAI collaboration for artificial intelligence-based digital pathology applications for improved patient care
Roche announces PathAI collaboration for artificial intelligence-based digital pathology applications for improved patient care
Pharmacology - Oct 15
US FDA approves Roche's Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer
US FDA approves Roche's Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer
Pharmacology - Oct 14
Roche's Gazyvaro shorter 90-minute infusion time approved in Europe for people with previously treated or untreated follicular lymphoma
Roche's Gazyvaro shorter 90-minute infusion time approved in Europe for people with previously treated or untreated follicular lymphoma